撒哈拉以南非洲早产儿视网膜病变的当前管理。
Current management of retinopathy of prematurity in sub-Saharan Africa.
机构信息
Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California.
Department of Ophthalmology, Stein Eye Institute, University of California Los Angeles, Los Angeles, California.
出版信息
J AAPOS. 2020 Jun;24(3):151.e1-151.e6. doi: 10.1016/j.jaapos.2020.03.002. Epub 2020 Jun 4.
PURPOSE
To survey current oxygen management, screening criteria, and methods for treating retinopathy of prematurity (ROP) in sub-Saharan Africa.
METHODS
An online survey was sent to ophthalmologists and neonatologists practicing in sub-Saharan Africa.
RESULTS
Ophthalmologists and neonatologists from 15 of 49 countries (31%) in sub-Saharan Africa responded. Neonatologists reported treating a median of 15 infants with supplemental oxygen per week but only had a median of 3.5 oxygen-measuring devices and a median of zero oxygen blenders in their units. Ophthalmologists reported screening a median of 5 infants per week for ROP and treating 2 infants each month for ROP. Most ophthalmologists (24/27 [89%]) had access to anti-vascular endothelial growth factor drugs to treat ROP, but only 13 of 27 (48%) had access to a laser.
CONCLUSIONS
Survey results reveal an urgent need for additional oxygen- management equipment in hospitals in sub-Saharan Africa.
目的
调查撒哈拉以南非洲地区目前在氧气管理、筛查标准和早产儿视网膜病变（ROP）治疗方法方面的情况。
方法
向在撒哈拉以南非洲地区执业的眼科医生和新生儿科医生发送了在线调查。
结果
来自撒哈拉以南非洲 49 个国家中的 15 个国家（31%）的眼科医生和新生儿科医生做出了回应。新生儿科医生报告称，他们每周治疗的需要补充氧气的婴儿中位数为 15 名，但他们的单位中仅有中位数为 3.5 个的氧气测量设备和中位数为零的氧气混合器。眼科医生报告称，他们每周对中位数为 5 名婴儿进行 ROP 筛查，并每月对 2 名婴儿进行 ROP 治疗。大多数眼科医生（24/27 [89%]）可以获得用于治疗 ROP 的抗血管内皮生长因子药物，但只有 27 名中的 13 名（48%）可以获得激光。
结论
调查结果显示，撒哈拉以南非洲地区的医院急需更多的氧气管理设备。
Zotero 插件